CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN AUTOIMMUNE LIVER-DISEASE AND EVIDENCE FOR THE PRODUCTION OF ICAM-1 BY CYTOKINE-STIMULATED HUMAN HEPATOCYTES
Aw. Thomson et al., CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN AUTOIMMUNE LIVER-DISEASE AND EVIDENCE FOR THE PRODUCTION OF ICAM-1 BY CYTOKINE-STIMULATED HUMAN HEPATOCYTES, Clinical and experimental immunology, 95(1), 1994, pp. 83-90
A circulating form of the membrane-bound ICAM-1 (CD54), a ligand for l
ymphocyte function-associated antigen-1 (LFA-1), has recently been ide
ntified in normal human serum. In this study, serum levels of soluble
ICAM-1 (sICAM-1) were determined by sandwich ELISA both in normal heal
thy individuals of both sexes and in subjects with autoimmune liver di
seases. Patients with primary biliary cirrhosis (PBC), primary scleros
ing cholangitis and chronic active hepatitis (autoimmune) showed signi
ficant elevations in sICAM-1 compared with normal healthy subjects. Th
e median level in PBC was approximately seven-fold above normal. Signi
ficant elevations in sICAM-1 were also detected, however, in patients
with inactive alcoholic cirrhosis, suggesting that impaired liver clea
rance might at least in part account for the increased serum levels se
en in patients with autoimmune liver disease. In patients with PBC, sI
CAM-1 levels were related to summary assessment of disease severity (C
hild-Pugh classification) and correlated significantly with serum bioc
hemical indices of liver function, including measures both of cholesta
sis and liver cell injury. In contrast, serum levels of E-selectin did
not differ significantly from healthy controls. Although it has been
suggested that peripheral blood mononuclear cells (PBMC) may be a sour
ce of sICAM-1, investigation of ICAM-1 gene expression by reverse tran
scriptase polymerase chain reaction revealed similar basal levels of I
CAM-1 message in PBMC of normal individuals and those with active PBC.
This suggests that PBMC may not be a significant source of sICAM-1 in
this disease. Similar increases in ICAM-1 mRNA expression were found
in cultured, concanavalin A (Con A)-stimulated lymphocytes of both PBC
patients and controls. Significantly, stimulation of cultured, normal
human hepatocytes with proinflammatory cytokines and endotoxin induce
d cell surface expression of ICAM-1 and the secretion/shedding of sICA
M-1 into the hepatocyte culture medium. This new finding suggests that
hepatocytes may be an important source of sICAM-1 in autoimmune and o
ther chronic liver diseases. The possible role of sICAM-1 in inflammat
ory disorders remains to be determined.